Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 12:51 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2521–2544 of 4,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ADM Clear all

Conditions: Prostate Cancer
Interventions: Epirubicin, Estramustine Phosphate, Celecoxib; Drug
Lead sponsor: Department of Veterans Affairs, New Jersey; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: East Orange, New Jersey

Conditions: Optic Nerve Disease, Macular Disease, Visual Pathway Disorder
Interventions: EyeCTester; Device
Lead sponsor: Neuro-Eye Diagnostic Systems, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Bellaire, Texas

Conditions: Triple Negative Breast Cancer, Breast Cancer
Interventions: Carboplatin, Docetaxel, Doxorubicin, Cyclophosphamide, Pembrolizumab; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 7
States / cities: Fairway, Kansas • Kansas City, Kansas • Overland Park, Kansas + 3 more

Conditions: Rhytidoplasty
Interventions: clonidine, glycopyrrolate, propofol, ketamine, marcaine, scopolamine, midazolam, ondansetron, metoclopramide, lidocaine, famotidine, desflurane, sevoflurane; Drug · Device
Lead sponsor: Mercy Facial Plastic Surgery Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Health Knowledge, Attitudes, Practice, Vaccine-Preventable Diseases, Intention, Adherence, Patient
Interventions: Culturally Tailored Multimedia Psychoeducational HPV Intervention, General HPV Multimedia Psychoeducational Control Group; Behavioral
Lead sponsor: University of Texas, El Paso; Other
Eligibility: 18 Years to 45 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Traumatic Lacerations
Interventions: Vicryl Rapide absorbable suture; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 2
States / cities: Fresno, California

Conditions: Insomnia, Hypnotic Dependence
Interventions: Digital Cognitive Behavioral Therapy, Structured Medication Tapering; Behavioral
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Hernia, Hernia Abdominal Wall, Ventral Hernia, Inguinal Hernia, Hiatal Hernia, Diastasis Recti
Interventions: Image-Guided Herniorrhaphy; Procedure
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Interstitial Cystitis, Painful Bladder Syndrome, Painful Bladder Syndrome (PBS)
Interventions: Clarix Flo, Placebo; Drug
Lead sponsor: David Sheyn; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Clevleand, Ohio

Conditions: Binge Eating, Binge-Eating Disorder, Weight Gain Prevention, Obesity
Interventions: Centering Appetite; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cancer
Interventions: Behavioral Intervention; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 39 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Preterm Birth
Interventions: Intervention Arm Weekly IP3 text messages, Active Control Arm General pregnancy text messages; Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Breast Cancer, Breast Benign
Interventions: Breast MRI, Breast Mammogram, Blood draw, Breast Biopsy, online participant reported questionnaire; Device · Other · Procedure + 1 more
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 628 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 7
States / cities: Hartford, Connecticut • Miami, Florida • Basking Ridge, New Jersey + 4 more

Conditions: Sport-related Concussion, Brain Concussion, Healthy
Interventions: Neck Strengthening; Other
Lead sponsor: University of Michigan; Other
Eligibility: 12 Years to 19 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Skin Pigment
Interventions: Survey administration for Fitzpatrick skin type, Measurement of ITA based on SkinColorCatch instrument; Other · Device
Lead sponsor: Integrative Skin Science and Research; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Rhinosinusitis Chronic, Sinus Cancer, Sinus Polyp, Encephalocele
Interventions: Tranexamic acid injection, Total Intravenous Anesthesia, Inhalational isoflurane; Drug
Lead sponsor: Our Lady of the Lake Hospital; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Post Induction Hypotension
Interventions: Group 1: LEE; Procedure
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 70 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Inflammatory Response
Interventions: Ibuprofen, Placebo/Saline solution; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Brooklyn, New York • New York, New York

Conditions: Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Non-small Cell Lung Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4, Advanced Breast Cancer, Advanced Lung Carcinoma, NSCLC, NSCLC, Recurrent, NSCLC Stage IV, Relapsed Cancer, Relapse/Recurrence, Recurrent Breast Cancer, Recurrent NSCLC, Platinum-resistant Ovarian Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Endometrioid Tumor, High Grade Serous Carcinoma, Ovarian Epithelial Cancer
Interventions: LYL797; Biological
Lead sponsor: Lyell Immunopharma, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 18
States / cities: Scottsdale, Arizona • Santa Monica, California • New Haven, Connecticut + 15 more

Conditions: Surgical Wound
Interventions: LiquiBand Exceed, LiquiBand Rapid; Device
Lead sponsor: Advanced Medical Solutions Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 4
States / cities: Columbus, Ohio • Greenville, South Carolina • Greer, South Carolina

Conditions: Cat Allergy
Interventions: Omalizumab, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Tobacco Use Disorder
Interventions: Tobacco Use Disorder, Standard Web-based intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 792 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2009
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Melanoma, Adolescents
Interventions: Skin cancer prevention educational presentation and activities; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 11 Years to 21 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Type 2 Diabetes, Inpatient Hyperglycemia
Interventions: Insulin glargine, Regular insulin, Insulin glulisine; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 2
States / cities: Atlanta, Georgia

Search by objective public record fields.

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Implementation of the NEDS EyeCTester App

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

Anesthetics in Rhytidoplasty - A Comparison Study

Culturally Tailored HPV Psychoeducational Multimedia Intervention

Vicryl Rapide Versus Nonabsorbable Suture

Enhancing Hypnotic Medication Discontinuation in Primary Care

Image-Guided Herniorrhaphy Study

Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome

Treating Binge Eating and Obesity Digitally in Women

A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer

Improving the Clinical Encounter to Enhance Delivery of an Individualized Prematurity Prevention Plan

Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening

Evaluation of a Neck Strengthening Program to Reduce the Risk of Sport-related Concussion

Correlation Between Objective Skin Pigment Measurement and Fitzpatrick Skin Type

TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality

Lower Extremity Elevation to Minimize Hemodynamic Instability During Induction of General Anesthesia

Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia.

A Study to Investigate LYL797 in Adults With Solid Tumors

LiquiBand® Exceed™ and LiquiBand® Rapid™ for General Surgery Procedures

The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge

LGBT Internet Based Smoking Treatment - 1

Sun Protection and Tanning Awareness in Rural Schools

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery